Nippon Shinyaku Co., Ltd. (NPNKF)
OTCMKTS
· Delayed Price · Currency is USD
23.58
0.00 (0.00%)
May 21, 2025, 4:00 PM EDT
Nippon Shinyaku Revenue
In the fiscal year ending March 31, 2025, Nippon Shinyaku had annual revenue of 160.23B JPY with 8.08% growth. Nippon Shinyaku had revenue of 38.91B in the quarter ending March 31, 2025, with 9.53% growth.
Revenue
160.23B JPY
Revenue Growth
+8.08%
P/S Ratio
1.50
Revenue / Employee
72.40M JPY
Employees
2,213
Market Cap
1.60B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 160.23B | 11.98B | 8.08% |
Mar 31, 2024 | 148.26B | 4.08B | 2.83% |
Mar 31, 2023 | 144.18B | 6.69B | 4.87% |
Mar 31, 2022 | 137.48B | 15.60B | 12.80% |
Mar 31, 2021 | 121.89B | 5.25B | 4.50% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
American Oncology Network | 1.76B |